The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
| PJARX | VSCAX | PJARX / VSCAX | |
| Total Expense Ratio | 1.45 | 1.10 | 132% |
| Annual Report Gross Expense Ratio | 1.47 | 1.10 | 134% |
| Fund Existence | 22 years | 27 years | - |
| Gain YTD | 17.681 | 24.970 | 71% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.26B | 11.4B | 11% |
| Annual Yield % from dividends | 0.71 | 0.21 | 346% |
| Returns for 1 year | 11.11 | 26.09 | 43% |
| Returns for 3 years | 18.62 | 61.96 | 30% |
| Returns for 5 years | -4.82 | 58.92 | -8% |
| Returns for 10 years | 7.97 | 91.54 | 9% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WSTYX | 96.75 | 1.02 | +1.07% |
| Nomura Science and Technology Y | |||
| AMGIX | 46.26 | N/A | N/A |
| American Century Disciplined Value I | |||
| MNMRX | 14.98 | N/A | N/A |
| Manning & Napier Pro-Blend Mod Term R | |||
| FSYMX | 13.26 | N/A | N/A |
| Fidelity Advisor Sustainable Intl Eq M | |||
| DLRHX | 27.77 | -0.22 | -0.79% |
| Nomura Healthcare Fund Class R | |||